These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 29348829)
1. Roflumilast restores cAMP/PKA/CREB signaling axis for FtMt-mediated tumor inhibition of ovarian cancer. Gong S; Chen Y; Meng F; Zhang Y; Wu H; Wu F Oncotarget; 2017 Dec; 8(68):112341-112353. PubMed ID: 29348829 [TBL] [Abstract][Full Text] [Related]
2. Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis. Gong S; Chen Y; Meng F; Zhang Y; Li C; Zhang G; Huan W; Wu F Cell Prolif; 2018 Oct; 51(5):e12474. PubMed ID: 30069985 [TBL] [Abstract][Full Text] [Related]
3. p-CREB and p-DARPP-32 orchestrating the modulatory role of cAMP/PKA signaling pathway enhanced by Roflumilast in rotenone-induced Parkinson's disease in rats. Essam RM; Kandil EA Chem Biol Interact; 2023 Feb; 372():110366. PubMed ID: 36706892 [TBL] [Abstract][Full Text] [Related]
19. Prevention of vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by CREB-mediated p21 induction: An insight from a plant polyphenol. Sun L; Zhao R; Zhang L; Zhang W; He G; Yang S; Song J; Du G Biochem Pharmacol; 2016 Mar; 103():40-52. PubMed ID: 26807478 [TBL] [Abstract][Full Text] [Related]